Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 792

1.

Expression of the retinoblastoma protein in low-grade B-cell lymphoma: relationship to cyclin D1.

Zukerberg LR, Benedict WF, Arnold A, Dyson N, Harlow E, Harris NL.

Blood. 1996 Jul 1;88(1):268-76.

2.

Cyclin D1 expression in non-Hodgkin's lymphomas. Detection by immunohistochemistry.

Zukerberg LR, Yang WI, Arnold A, Harris NL.

Am J Clin Pathol. 1995 Jun;103(6):756-60.

PMID:
7540362
3.

Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity.

Jares P, Campo E, Pinyol M, Bosch F, Miquel R, Fernandez PL, Sanchez-Beato M, Soler F, Perez-Losada A, Nayach I, Mallofré C, Piris MA, Montserrat E, Cardesa A.

Am J Pathol. 1996 May;148(5):1591-600.

4.

Cyclin D1 expression in mantle cell lymphoma is accompanied by downregulation of cyclin D3 and is not related to the proliferative activity.

Ott MM, Bartkova J, Bartek J, Dürr A, Fischer L, Ott G, Müller-Hermelink HK, Kreipe H.

Blood. 1997 Oct 15;90(8):3154-9.

5.

p27(Kip1) immunostaining for the differential diagnosis of small b-cell neoplasms in trephine bone marrow biopsies.

Kremer M, Dirnhofer S, Nickl A, Hoefler H, Quintanilla-Martínez L, Fend F.

Mod Pathol. 2001 Oct;14(10):1022-9.

6.

Cyclin D1 immunohistochemical staining is useful in distinguishing mantle cell lymphoma from other low-grade B-cell neoplasms in bone marrow.

Vasef MA, Medeiros LJ, Koo C, McCourty A, Brynes RK.

Am J Clin Pathol. 1997 Sep;108(3):302-7.

PMID:
9291459
7.

Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line.

Hochhauser D, Schnieders B, Ercikan-Abali E, Gorlick R, Muise-Helmericks R, Li WW, Fan J, Banerjee D, Bertino JR.

J Natl Cancer Inst. 1996 Sep 18;88(18):1269-75.

PMID:
8797766
8.

Immunohistochemical analysis of cyclin D1 protein in hematopoietic neoplasms with special reference to mantle cell lymphoma.

Nakamura S, Seto M, Banno S, Suzuki S, Koshikawa T, Kitoh K, Kagami Y, Ogura M, Yatabe Y, Kojima M, et al.

Jpn J Cancer Res. 1994 Dec;85(12):1270-9.

PMID:
7531681
9.

Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.

Specht K, Kremer M, Müller U, Dirnhofer S, Rosemann M, Höfler H, Quintanilla-Martinez L, Fend F.

Clin Cancer Res. 2002 Sep;8(9):2902-11.

10.

Clinicopathologic study of primary gastric lymphoma of B cell phenotype with special reference to low-grade B cell lymphoma of mucosa-associated lymphoid tissue among the Japanese.

Akaza K, Motoori T, Nakamura S, Koshikawa T, Kitoh K, Futamura N, Nakamura T, Kojima M, Kuroda M, Kasahara M, et al.

Pathol Int. 1995 Nov;45(11):832-45.

PMID:
8581146
11.

Anomalous high p27/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. p27/KIP1-cyclin D3 colocalization in tumor cells.

Sánchez-Beato M, Camacho FI, Martínez-Montero JC, Sáez AI, Villuendas R, Sánchez-Verde L, García JF, Piris MA.

Blood. 1999 Jul 15;94(2):765-72.

12.

Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.

Dreyling MH, Bullinger L, Ott G, Stilgenbauer S, Müller-Hermelink HK, Bentz M, Hiddemann W, Döhner H.

Cancer Res. 1997 Oct 15;57(20):4608-14.

13.

NF-kappa B-dependent induction of cyclin D1 by retinoblastoma protein (pRB) family proteins and tumor-derived pRB mutants.

Takebayashi T, Higashi H, Sudo H, Ozawa H, Suzuki E, Shirado O, Katoh H, Hatakeyama M.

J Biol Chem. 2003 Apr 25;278(17):14897-905. Epub 2003 Feb 19.

14.

p21 is associated with cyclin D1, p16INK4a and pRb expression in resectable non-small cell lung cancer.

Vonlanthen S, Heighway J, Kappeler A, Altermatt HJ, Borner MM, Betticher DC.

Int J Oncol. 2000 May;16(5):951-7.

PMID:
10762631
15.

Physical interaction of the retinoblastoma protein with human D cyclins.

Dowdy SF, Hinds PW, Louie K, Reed SI, Arnold A, Weinberg RA.

Cell. 1993 May 7;73(3):499-511.

PMID:
8490963
16.

The morphologic spectrum of non-Hodgkin's lymphomas with BCL1/cyclin D1 gene rearrangements.

Swerdlow SH, Zukerberg LR, Yang WI, Harris NL, Williams ME.

Am J Surg Pathol. 1996 May;20(5):627-40.

PMID:
8619427
17.

BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts.

Onizuka T, Moriyama M, Yamochi T, Kuroda T, Kazama A, Kanazawa N, Sato K, Kato T, Ota H, Mori S.

Blood. 1995 Jul 1;86(1):28-37.

18.

CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation.

Bellan C, De Falco G, Lazzi S, Micheli P, Vicidomini S, Schürfeld K, Amato T, Palumbo A, Bagella L, Sabattini E, Bartolommei S, Hummel M, Pileri S, Tosi P, Leoncini L, Giordano A.

J Pathol. 2004 Aug;203(4):946-52.

PMID:
15258998
19.
20.

Molecular control of the cell cycle in cancer: biological and clinical aspects.

Møller MB.

Dan Med Bull. 2003 May;50(2):118-38. Review.

PMID:
12812137

Supplemental Content

Support Center